Bone mineral density, osteocalcin, and bone-specific alkaline phosphatase in patients with insulin-dependent diabetes mellitus

Annals of the New York Academy of Sciences

Volumn 1173, Issue SUPPL. 1, 2009, Pages

  Lumachi, Franco ^a   Camozzi, Valentina ^b   Tombolan, Valeria ^a   Luisetto, Giovanni ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b Division of Endocrinology   (Italy)

Author keywords

alkaline phosphatase; bone mineral density; diabetes mellitus; osteocalcin; osteodensitometry; osteopenia

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; OSTEOCALCIN; ALKALINE PHOSPHATASE; CREATININE; PARATHYROID HORMONE;

ADULT; ARTICLE; BODY MASS; BONE DENSITOMETRY; BONE DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMUR NECK; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LUMBAR SPINE; MALE; OSTEOPENIA; PREVALENCE; BLOOD; ENZYMOLOGY; METABOLIC BONE DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY; REFERENCE VALUE;

ADULT; ALKALINE PHOSPHATASE; BONE DENSITY; BONE DISEASES, METABOLIC; CREATININE; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOCALCIN; PARATHYROID HORMONE; REFERENCE VALUES;

EID: 70350445035     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04955.x     Document Type: Article

References (20)

1. Cummings, S.R. 2006. A 55-year old women with osteopenia. JAMA 296: 2601-2610.
2. Shoback, D. et al. 2001. Mineral metabolism & metabolic bone disease. In Basic and Clinical Endocrinology. F.S. Greenspan & D.G. Gardner, Eds.: 273-333 LangeMedical Book/McGraw-Hill. New York, NY. 3.
3. LangeMedical Book/McGraw-Hill. New York, NY. 3. Becker, C. 2006. Pathophysiology and clinical manifestations of osteoporosis. Clin. Cornerstone 8: 19-27.
4. Calvo, M.E., D.R. Eyre & C.M. Grundberg. 1996. Molecular basis and clinical application of biological markers of bone turnover. Endocrine Rev. 17: 333-368.
5. Grundberg, C.M., A.C. Lloker, S.D. Nieman, et al. 2002. Patterns of osteocalcin and bone specific alkaline phosphatase by age, gender, and race or ethnicity. Bone 31: 703-708.
6. Lee, N.K., H. Sowa, E. Hinoi, et al. 2007. Endocrine regulation of energy metabolism by skeleton. Cell 130: 456-469.
7. Lumachi, F., M. Ermani, F. Marino, et al. 2006. PCNA-LI, Ki-67 immunostaining, p53 activity and histopathological variables in predicting the clinical outcome in patients with parathyroid carcinoma. Anticancer Res. 25: 1305-1308.
8. Lumachi, F., V. Camozzi, M. Ermani, et al. 2007. Bone mineral density improvement after successful parathyroidectomy in pre- and postmenopausal women with primary hyperparathyroidism. Ann. N. Y. Acad. Sci. 1117: 357-361.
9. Camozzi, V., F. Lumachi, M. Piccolo, et al. 2003. Phalangeal quantitative ultrasound technology and dual energy X-ray densitometry in patients with primary hyperparathyroidism: influence of sex and menopausal status. Osteoporos. Int. 14: 602-608.
10. Garnero, P., E. Hausherp, M.C. Chapuy, et al. 1996. Markers of bone resorption predict hip fracture in elderly women: The EDIPOS prospective study. J. Bone Miner. Res. 11: 1531-1538.
11. Stewart, A., V. Kumar & D.M. Reid. 2006. Longtermfracture prediction byDEXandQUS: a 10-year prospective study. J. Bone Miner. Res. 21: 413-418.
12. Masharani, U. & J.M. Karam. 2001. Pancreatic hormones & diabetes mellitus. In Basic and Clinical Endocrinology. F.S. Greenspan & D.G. Gardner, Eds.: 623-698. Lange Medical Book/McGraw-Hill. New York, NY.
13. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. 2001. Osteoporosis prevention, diagnosis, and therapy. JAMA 285: 785-795.
14. Delmas, P.D., R. Eastell, P. Gardner, et al. Committee of Scientific Advisors of the International Osteoporosis Foundation. 2000. The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisor of the International Osteoporosis Foundation. Osteoporos. Int. 11: S2-S17.
15. Reginster, J.-Y., J. Collette, A. Neuprez, et al. 2008. Role of biochemical markers of bone turnover as prognostic indicator of successful osteoporosis therapy. Bone 42: 832-836.
16. Ferron,M., E. Hinoi,G.Karsenty, et al. 2008. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc. Natl. Acad. Sci. USA 105: 5266-5270.
17. Duarte, V.M.G., A.M.O. Ramos, L.A. Rezende, et al. 2005. Osteopenia: a bone disorder associated with diabetes mellitus. J. Bone Min. Metab. 23: 58-68.
18. Horuchi, T., H. Kazama, A. Araki, et al. 2004. Impaired gamma carboxylation of osteocalcin in elderly womenwith type II diabetesmellitus: relationship between increase in udecarboxylated osteocalcin and low bone mineral density. J. Bone Miner. Metab. 22: 236-240.
19. Kemink, S.A., A.R. Hermus, L.M. Swinkels, et al. 2000. Osteopenia in insulin-dependent diabetesmellitus; prevalence and aspects of pathophysiology. J. Endocrinol. Invest. 23: 295-303.
20. Gunczler, P., R. Lanes, V. Paz-Martinez, et al. 1998. Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally. J. Pediatr. Endocrinol. Metab. 11: 413-419.